search
Back to results

Neuronal Inertia in Propofol Anesthesia (INERTIA)

Primary Purpose

General Anesthesia, Propofol Pharmacodynamics, Propofol Target Controlled Infusion

Status
Completed
Phase
Phase 4
Locations
Chile
Study Type
Interventional
Intervention
propofol targel controlled infusion
Sponsored by
Universidad del Desarrollo
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for General Anesthesia focused on measuring neuronal inertia, loss of consciousness, propofol pharmacodynamics, Bispectral index, anesthesia, general/pharmacology

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • american society of anesthesiologists status I or II age >18 years fasted at least 8 hours BMI<30

Exclusion Criteria:

  • any known adverse reaction to propofol administration soy or egg-protein allergy psychotropic use (illegal of medically indicated)

Sites / Locations

  • Clinica Alemana de Santiago

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

propofol slow infusion

Arm Description

(healthy volunteers, non invasive monitoring and O2 supply via nasal cannula) Target controlled infusion of propofol using Schnider´s pharmacokinetic parameters in a slow, stepped fashion. beginning at Cp 0.5 mcg/ml and increasing in 0.5 mcg/ml every 7 minutes until LOC occurred, then a prolonged step of 14 minutes (2 samples), increase 2 steps further and then decrease in 0.5 mcg/ml steps until ROC and a 7 minute registry after ROC. Blood sampling for propofol plasma level every 7 minutes (at the end of each step, allowing for pseudo-equilibrium condition. 32 channel-EEg and BIS continuous monitoring

Outcomes

Primary Outcome Measures

plasma-equilibrated effect site concentration of propofol at LOC and ROC (mcg/ml)
determination of plasma concentration of PROPOFOL at the time of Loss of Consciousness and the time of recovery of consciousness during the 7-minute step infusion. Provided it is a slow increasing infusion we assume a pseudo-equilibrium state between plasma and effect site. the existence of a difference between these two values will support the hypothesis of neuronal inertia

Secondary Outcome Measures

Bispectral Index (BIS) al LOC and ROC
we measured the BISPECTRAL INDEX all through the protocol: from previous to start the infusion until 7 minutes after recovery of consciousness. values of BIS at LOC and ROC will be compared. a potential difference found between those two values supports the theory thas LOC and ROC reflects different neuronal processes Other clinically relevant endpoints (loss of palpebral reflex, onset of amnesia) will be registered in order to build the pharmacodynamic loop.
Pharmacodynamic curve for propofol.
plasma concentration of PROPOFOL (mcg/ml) at other clinically relevant endpoints (amnesia onset, loss of palpebral reflex, etc...) will be determined in order to build a pharmacodynamic curve,
PROPOFOL effect site concentration during infusion
plasma concentration of PROPOFOL (mcg/ml) from venous blood samples will be determinated every 7 minutes, that means at the end of each TCI step. assuming the 7-minute step gave enough time to reach a pseudo-equilibrium state, we consider the results comparable to effect site concentration.

Full Information

First Posted
October 9, 2013
Last Updated
October 11, 2013
Sponsor
Universidad del Desarrollo
search

1. Study Identification

Unique Protocol Identification Number
NCT01962285
Brief Title
Neuronal Inertia in Propofol Anesthesia
Acronym
INERTIA
Official Title
Neuronal Inertia´s Effect on Pharmacological Behavior Representation of Propofol
Study Type
Interventional

2. Study Status

Record Verification Date
October 2013
Overall Recruitment Status
Completed
Study Start Date
August 2013 (undefined)
Primary Completion Date
September 2013 (Actual)
Study Completion Date
October 2013 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Universidad del Desarrollo

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Loss and recovery of consciousness during propofol anesthesia seem to be mediated by different mechanisms beyond the actual effect-site concentration of anesthetic drug. This eventual difference between dose response curves for loss of consciousness (LOC) and for recovery of consciousness (ROC) beyond hysteresis has received the name of neuronal inertia. We performed a volunteer-study comparing LOC and ROC curves during a slow, steady-sate, stepped target controlled infusion of Propofol. Our hypothesis is that, at steady-state conditions between plasma an effect-site concentration, there is still going to exist a difference between LOC and ROC, demonstrating the existence of neuronal inertia.
Detailed Description
Loss and recovery of consciousness during propofol anesthesia seem to be mediated by different mechanisms beyond the actual effect-site concentration of anesthetic drug. This eventual difference between dose response curves for loss of consciousness (LOC) and for recovery of consciousness (ROC) beyond hysteresis has received the name of neuronal inertia. We performed a volunteer-study comparing LOC and ROC curves, during a slow, steady-sate, stepped target controlled infusion of Propofol using Schnider's pharmacologic model. Our hypothesis is that, at steady-state conditions between plasma an effect-site concentration, there is still going to exist a difference between LOC and ROC, demonstrating the existence of neuronal inertia.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
General Anesthesia, Propofol Pharmacodynamics, Propofol Target Controlled Infusion, Loss of Consciousness and Recovery of Consciousness, Propofol Plasma Concentration
Keywords
neuronal inertia, loss of consciousness, propofol pharmacodynamics, Bispectral index, anesthesia, general/pharmacology

7. Study Design

Primary Purpose
Basic Science
Study Phase
Phase 4
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
14 (Actual)

8. Arms, Groups, and Interventions

Arm Title
propofol slow infusion
Arm Type
Experimental
Arm Description
(healthy volunteers, non invasive monitoring and O2 supply via nasal cannula) Target controlled infusion of propofol using Schnider´s pharmacokinetic parameters in a slow, stepped fashion. beginning at Cp 0.5 mcg/ml and increasing in 0.5 mcg/ml every 7 minutes until LOC occurred, then a prolonged step of 14 minutes (2 samples), increase 2 steps further and then decrease in 0.5 mcg/ml steps until ROC and a 7 minute registry after ROC. Blood sampling for propofol plasma level every 7 minutes (at the end of each step, allowing for pseudo-equilibrium condition. 32 channel-EEg and BIS continuous monitoring
Intervention Type
Drug
Intervention Name(s)
propofol targel controlled infusion
Other Intervention Name(s)
propofol TCI
Intervention Description
slow stepped propofol target controlled infusion using Schinider´s pharmacokinetic parameters seriated venous blood sampling
Primary Outcome Measure Information:
Title
plasma-equilibrated effect site concentration of propofol at LOC and ROC (mcg/ml)
Description
determination of plasma concentration of PROPOFOL at the time of Loss of Consciousness and the time of recovery of consciousness during the 7-minute step infusion. Provided it is a slow increasing infusion we assume a pseudo-equilibrium state between plasma and effect site. the existence of a difference between these two values will support the hypothesis of neuronal inertia
Time Frame
2 hours (during slow steady-state concentration propofol infusion)
Secondary Outcome Measure Information:
Title
Bispectral Index (BIS) al LOC and ROC
Description
we measured the BISPECTRAL INDEX all through the protocol: from previous to start the infusion until 7 minutes after recovery of consciousness. values of BIS at LOC and ROC will be compared. a potential difference found between those two values supports the theory thas LOC and ROC reflects different neuronal processes Other clinically relevant endpoints (loss of palpebral reflex, onset of amnesia) will be registered in order to build the pharmacodynamic loop.
Time Frame
2 hours (during slow increasing TCI (Target controlled Infusion) of PROPOFOL
Title
Pharmacodynamic curve for propofol.
Description
plasma concentration of PROPOFOL (mcg/ml) at other clinically relevant endpoints (amnesia onset, loss of palpebral reflex, etc...) will be determined in order to build a pharmacodynamic curve,
Time Frame
2 hours
Title
PROPOFOL effect site concentration during infusion
Description
plasma concentration of PROPOFOL (mcg/ml) from venous blood samples will be determinated every 7 minutes, that means at the end of each TCI step. assuming the 7-minute step gave enough time to reach a pseudo-equilibrium state, we consider the results comparable to effect site concentration.
Time Frame
2 hours
Other Pre-specified Outcome Measures:
Title
performance of Schnider´s pharmacokinetic parameters in a slow infusion
Description
to compare plasma (and effect site) Propofol concentration predicted by the model with measured values thus evaluating model´s performance. Median performance error (MDPE) and median absolute performance error (MDAPE), divergence and other often reported parameters will be determinated.
Time Frame
2 hours
Title
Electroencephalographic behavior at LOC and ROC during Propofol infusion
Description
spectral analisis of 32-channel EEG during infusion. a specified time-frame around those two events (i.e.: 14 minutes) will be reconstructed in images and analyzed. cortical areas with enhanced activity and how do this activity changes during loss of consciousness and the recovery of it will be evaluated with a mathematical model in order two determine wether those events correspond with two different processes instead of a bidirectional single one.
Time Frame
2 hours (during propofol infusion)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: american society of anesthesiologists status I or II age >18 years fasted at least 8 hours BMI<30 Exclusion Criteria: any known adverse reaction to propofol administration soy or egg-protein allergy psychotropic use (illegal of medically indicated)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
pablo sepulveda, anesthesiologist
Organizational Affiliation
Universidad del Desarrollo
Official's Role
Principal Investigator
Facility Information:
Facility Name
Clinica Alemana de Santiago
City
Santiago
State/Province
Region Metropolitana
Country
Chile

12. IPD Sharing Statement

Learn more about this trial

Neuronal Inertia in Propofol Anesthesia

We'll reach out to this number within 24 hrs